141 related articles for article (PubMed ID: 16798009)
1. Expression and purification of functional human anthrax toxin receptor (ATR/TEM8) binding domain from Escherichia coli.
Ding Z; Bradley KA; Amin Arnaout M; Xiong JP
Protein Expr Purif; 2006 Sep; 49(1):121-8. PubMed ID: 16798009
[TBL] [Abstract][Full Text] [Related]
2. The structure of tumor endothelial marker 8 (TEM8) extracellular domain and implications for its receptor function for recognizing anthrax toxin.
Fu S; Tong X; Cai C; Zhao Y; Wu Y; Li Y; Xu J; Zhang XC; Xu L; Chen W; Rao Z
PLoS One; 2010 Jun; 5(6):e11203. PubMed ID: 20585457
[TBL] [Abstract][Full Text] [Related]
3. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
4. ATR/TEM8 is highly expressed in epithelial cells lining Bacillus anthracis' three sites of entry: implications for the pathogenesis of anthrax infection.
Bonuccelli G; Sotgia F; Frank PG; Williams TM; de Almeida CJ; Tanowitz HB; Scherer PE; Hotchkiss KA; Terman BI; Rollman B; Alileche A; Brojatsch J; Lisanti MP
Am J Physiol Cell Physiol; 2005 Jun; 288(6):C1402-10. PubMed ID: 15689409
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and preliminary X-ray analysis of the vWA domain of human anthrax toxin receptor 1.
Cai C; Zhao Y; Tong X; Fu S; Li Y; Wu Y; Li X; Lou Z
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Jan; 67(Pt 1):64-7. PubMed ID: 21206026
[TBL] [Abstract][Full Text] [Related]
6. The receptors that mediate the direct lethality of anthrax toxin.
Liu S; Zhang Y; Hoover B; Leppla SH
Toxins (Basel); 2012 Dec; 5(1):1-8. PubMed ID: 23271637
[TBL] [Abstract][Full Text] [Related]
7. Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting.
Chen KH; Liu S; Leysath CE; Miller-Randolph S; Zhang Y; Fattah R; Bugge TH; Leppla SH
J Biol Chem; 2016 Oct; 291(42):22021-22029. PubMed ID: 27555325
[TBL] [Abstract][Full Text] [Related]
8. Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo.
Liu S; Crown D; Miller-Randolph S; Moayeri M; Wang H; Hu H; Morley T; Leppla SH
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12424-9. PubMed ID: 19617532
[TBL] [Abstract][Full Text] [Related]
9. Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells.
Chen KH; Liu S; Bankston LA; Liddington RC; Leppla SH
J Biol Chem; 2007 Mar; 282(13):9834-9845. PubMed ID: 17251181
[TBL] [Abstract][Full Text] [Related]
10. Development of receptor-based inhibitory RNA aptamers for anthrax toxin neutralization.
Lee SC; Gedi V; Ha NR; Cho JH; Park HC; Yoon MY
Int J Biol Macromol; 2015; 77():293-302. PubMed ID: 25841381
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of the Bacillus anthracis protective antigen domain 4.
Krishnanchettiar S; Sen J; Caffrey M
Protein Expr Purif; 2003 Feb; 27(2):325-30. PubMed ID: 12597893
[TBL] [Abstract][Full Text] [Related]
12. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization.
Liu S; Leppla SH
J Biol Chem; 2003 Feb; 278(7):5227-34. PubMed ID: 12468536
[TBL] [Abstract][Full Text] [Related]
13. Disulfide bonds in the ectodomain of anthrax toxin receptor 2 are required for the receptor-bound protective-antigen pore to function.
Sun J; Collier RJ
PLoS One; 2010 May; 5(5):e10553. PubMed ID: 20479891
[TBL] [Abstract][Full Text] [Related]
14. Tumor endothelium marker-8 based decoys exhibit superiority over capillary morphogenesis protein-2 based decoys as anthrax toxin inhibitors.
Cai C; Che J; Xu L; Guo Q; Kong Y; Fu L; Xu J; Cheng Y; Chen W
PLoS One; 2011; 6(6):e20646. PubMed ID: 21674060
[TBL] [Abstract][Full Text] [Related]
15. Quantitative measurement of anthrax toxin receptor messenger RNA in primary mononuclear phagocytes.
Premanandan C; Lairmore MD; Fernandez S; Phipps AJ
Microb Pathog; 2006; 41(4-5):193-8. PubMed ID: 16854559
[TBL] [Abstract][Full Text] [Related]
16. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen.
Wigelsworth DJ; Krantz BA; Christensen KA; Lacy DB; Juris SJ; Collier RJ
J Biol Chem; 2004 May; 279(22):23349-56. PubMed ID: 15044490
[TBL] [Abstract][Full Text] [Related]
17. Anthrax toxin uptake by primary immune cells as determined with a lethal factor-beta-lactamase fusion protein.
Hu H; Leppla SH
PLoS One; 2009 Nov; 4(11):e7946. PubMed ID: 19956758
[TBL] [Abstract][Full Text] [Related]
18. Toxicity of anthrax toxin is influenced by receptor expression.
Taft SC; Weiss AA
Clin Vaccine Immunol; 2008 Sep; 15(9):1330-6. PubMed ID: 18596206
[TBL] [Abstract][Full Text] [Related]
19. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
20. Purification of anthrax edema factor from Escherichia coli and identification of residues required for binding to anthrax protective antigen.
Kumar P; Ahuja N; Bhatnagar R
Infect Immun; 2001 Oct; 69(10):6532-6. PubMed ID: 11553601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
